A large and apprently artificial collection of diverse kinetoplastid protein kinases. A subfamily has 2TM regions, but the majority is cytoplasmic.
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 9 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 13 |
NetGPI | no | yes: 0, no: 13 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 3 |
GO:0110165 | cellular anatomical entity | 1 | 3 |
Related structures:
AlphaFold database: Q4Q1Z0
Term | Name | Level | Count |
---|---|---|---|
GO:0000165 | MAPK cascade | 4 | 2 |
GO:0001932 | regulation of protein phosphorylation | 7 | 2 |
GO:0001934 | positive regulation of protein phosphorylation | 8 | 2 |
GO:0006468 | protein phosphorylation | 5 | 14 |
GO:0006793 | phosphorus metabolic process | 3 | 14 |
GO:0006796 | phosphate-containing compound metabolic process | 4 | 14 |
GO:0006807 | nitrogen compound metabolic process | 2 | 14 |
GO:0007165 | signal transduction | 2 | 2 |
GO:0008152 | metabolic process | 1 | 14 |
GO:0009893 | positive regulation of metabolic process | 4 | 2 |
GO:0009966 | regulation of signal transduction | 4 | 2 |
GO:0009967 | positive regulation of signal transduction | 5 | 2 |
GO:0009987 | cellular process | 1 | 14 |
GO:0010562 | positive regulation of phosphorus metabolic process | 6 | 2 |
GO:0010604 | positive regulation of macromolecule metabolic process | 5 | 2 |
GO:0010646 | regulation of cell communication | 4 | 2 |
GO:0010647 | positive regulation of cell communication | 5 | 2 |
GO:0016310 | phosphorylation | 5 | 14 |
GO:0019220 | regulation of phosphate metabolic process | 6 | 2 |
GO:0019222 | regulation of metabolic process | 3 | 2 |
GO:0019538 | protein metabolic process | 3 | 14 |
GO:0023051 | regulation of signaling | 3 | 2 |
GO:0023056 | positive regulation of signaling | 4 | 2 |
GO:0031323 | regulation of cellular metabolic process | 4 | 2 |
GO:0031325 | positive regulation of cellular metabolic process | 5 | 2 |
GO:0031399 | regulation of protein modification process | 6 | 2 |
GO:0031401 | positive regulation of protein modification process | 7 | 2 |
GO:0033674 | positive regulation of kinase activity | 6 | 2 |
GO:0035556 | intracellular signal transduction | 3 | 2 |
GO:0036211 | protein modification process | 4 | 14 |
GO:0042325 | regulation of phosphorylation | 7 | 2 |
GO:0042327 | positive regulation of phosphorylation | 8 | 2 |
GO:0043085 | positive regulation of catalytic activity | 4 | 2 |
GO:0043170 | macromolecule metabolic process | 3 | 14 |
GO:0043405 | regulation of MAP kinase activity | 8 | 2 |
GO:0043406 | positive regulation of MAP kinase activity | 8 | 2 |
GO:0043408 | regulation of MAPK cascade | 6 | 2 |
GO:0043410 | positive regulation of MAPK cascade | 7 | 2 |
GO:0043412 | macromolecule modification | 4 | 14 |
GO:0043549 | regulation of kinase activity | 5 | 2 |
GO:0044093 | positive regulation of molecular function | 3 | 2 |
GO:0044237 | cellular metabolic process | 2 | 14 |
GO:0044238 | primary metabolic process | 2 | 14 |
GO:0045859 | regulation of protein kinase activity | 6 | 2 |
GO:0045860 | positive regulation of protein kinase activity | 7 | 2 |
GO:0045937 | positive regulation of phosphate metabolic process | 7 | 2 |
GO:0046777 | protein autophosphorylation | 6 | 2 |
GO:0048518 | positive regulation of biological process | 3 | 2 |
GO:0048522 | positive regulation of cellular process | 4 | 2 |
GO:0048583 | regulation of response to stimulus | 3 | 2 |
GO:0048584 | positive regulation of response to stimulus | 4 | 2 |
GO:0050789 | regulation of biological process | 2 | 2 |
GO:0050790 | regulation of catalytic activity | 3 | 2 |
GO:0050794 | regulation of cellular process | 3 | 2 |
GO:0051171 | regulation of nitrogen compound metabolic process | 4 | 2 |
GO:0051173 | positive regulation of nitrogen compound metabolic process | 5 | 2 |
GO:0051174 | regulation of phosphorus metabolic process | 5 | 2 |
GO:0051246 | regulation of protein metabolic process | 5 | 2 |
GO:0051247 | positive regulation of protein metabolic process | 6 | 2 |
GO:0051338 | regulation of transferase activity | 4 | 2 |
GO:0051347 | positive regulation of transferase activity | 5 | 2 |
GO:0060255 | regulation of macromolecule metabolic process | 4 | 2 |
GO:0065007 | biological regulation | 1 | 2 |
GO:0065009 | regulation of molecular function | 2 | 2 |
GO:0071704 | organic substance metabolic process | 2 | 14 |
GO:0071900 | regulation of protein serine/threonine kinase activity | 7 | 2 |
GO:0071902 | positive regulation of protein serine/threonine kinase activity | 8 | 2 |
GO:0080090 | regulation of primary metabolic process | 4 | 2 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 14 |
GO:1902531 | regulation of intracellular signal transduction | 5 | 2 |
GO:1902533 | positive regulation of intracellular signal transduction | 6 | 2 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000166 | nucleotide binding | 3 | 14 |
GO:0003824 | catalytic activity | 1 | 14 |
GO:0004672 | protein kinase activity | 3 | 14 |
GO:0004708 | MAP kinase kinase activity | 5 | 2 |
GO:0004712 | protein serine/threonine/tyrosine kinase activity | 4 | 2 |
GO:0005488 | binding | 1 | 14 |
GO:0005515 | protein binding | 2 | 2 |
GO:0005524 | ATP binding | 5 | 14 |
GO:0016301 | kinase activity | 4 | 14 |
GO:0016740 | transferase activity | 2 | 14 |
GO:0016772 | transferase activity, transferring phosphorus-containing groups | 3 | 14 |
GO:0016773 | phosphotransferase activity, alcohol group as acceptor | 4 | 14 |
GO:0017076 | purine nucleotide binding | 4 | 14 |
GO:0019899 | enzyme binding | 3 | 2 |
GO:0019900 | kinase binding | 4 | 2 |
GO:0019901 | protein kinase binding | 5 | 2 |
GO:0030554 | adenyl nucleotide binding | 5 | 14 |
GO:0032553 | ribonucleotide binding | 3 | 14 |
GO:0032555 | purine ribonucleotide binding | 4 | 14 |
GO:0032559 | adenyl ribonucleotide binding | 5 | 14 |
GO:0035639 | purine ribonucleoside triphosphate binding | 4 | 14 |
GO:0036094 | small molecule binding | 2 | 14 |
GO:0043167 | ion binding | 2 | 14 |
GO:0043168 | anion binding | 3 | 14 |
GO:0051019 | mitogen-activated protein kinase binding | 6 | 2 |
GO:0097159 | organic cyclic compound binding | 2 | 14 |
GO:0097367 | carbohydrate derivative binding | 2 | 14 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 14 |
GO:1901265 | nucleoside phosphate binding | 3 | 14 |
GO:1901363 | heterocyclic compound binding | 2 | 14 |
GO:0004674 | protein serine/threonine kinase activity | 4 | 7 |
GO:0004707 | MAP kinase activity | 5 | 4 |
GO:0004140 | dephospho-CoA kinase activity | 5 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 136 | 140 | PF00656 | 0.288 |
CLV_C14_Caspase3-7 | 207 | 211 | PF00656 | 0.288 |
CLV_C14_Caspase3-7 | 430 | 434 | PF00656 | 0.557 |
CLV_NRD_NRD_1 | 102 | 104 | PF00675 | 0.270 |
CLV_NRD_NRD_1 | 304 | 306 | PF00675 | 0.448 |
CLV_NRD_NRD_1 | 414 | 416 | PF00675 | 0.666 |
CLV_NRD_NRD_1 | 74 | 76 | PF00675 | 0.323 |
CLV_PCSK_KEX2_1 | 102 | 104 | PF00082 | 0.291 |
CLV_PCSK_KEX2_1 | 304 | 306 | PF00082 | 0.382 |
CLV_PCSK_KEX2_1 | 74 | 76 | PF00082 | 0.352 |
CLV_PCSK_SKI1_1 | 159 | 163 | PF00082 | 0.339 |
CLV_PCSK_SKI1_1 | 177 | 181 | PF00082 | 0.448 |
CLV_PCSK_SKI1_1 | 404 | 408 | PF00082 | 0.524 |
CLV_PCSK_SKI1_1 | 486 | 490 | PF00082 | 0.577 |
CLV_PCSK_SKI1_1 | 88 | 92 | PF00082 | 0.343 |
CLV_Separin_Metazoa | 310 | 314 | PF03568 | 0.382 |
DEG_APCC_DBOX_1 | 101 | 109 | PF00400 | 0.288 |
DEG_APCC_DBOX_1 | 158 | 166 | PF00400 | 0.288 |
DOC_CKS1_1 | 113 | 118 | PF01111 | 0.390 |
DOC_CKS1_1 | 334 | 339 | PF01111 | 0.505 |
DOC_CYCLIN_yClb1_LxF_4 | 509 | 514 | PF00134 | 0.572 |
DOC_CYCLIN_yCln2_LP_2 | 145 | 151 | PF00134 | 0.319 |
DOC_CYCLIN_yCln2_LP_2 | 312 | 318 | PF00134 | 0.280 |
DOC_MAPK_gen_1 | 79 | 87 | PF00069 | 0.342 |
DOC_PP2B_LxvP_1 | 280 | 283 | PF13499 | 0.382 |
DOC_PP4_FxxP_1 | 113 | 116 | PF00568 | 0.442 |
DOC_USP7_MATH_1 | 348 | 352 | PF00917 | 0.632 |
DOC_USP7_MATH_1 | 355 | 359 | PF00917 | 0.585 |
DOC_USP7_MATH_1 | 361 | 365 | PF00917 | 0.640 |
DOC_USP7_MATH_1 | 424 | 428 | PF00917 | 0.644 |
DOC_USP7_MATH_1 | 431 | 435 | PF00917 | 0.563 |
DOC_USP7_MATH_1 | 441 | 445 | PF00917 | 0.559 |
DOC_USP7_MATH_2 | 283 | 289 | PF00917 | 0.280 |
DOC_WW_Pin1_4 | 112 | 117 | PF00397 | 0.323 |
DOC_WW_Pin1_4 | 219 | 224 | PF00397 | 0.288 |
DOC_WW_Pin1_4 | 298 | 303 | PF00397 | 0.319 |
DOC_WW_Pin1_4 | 333 | 338 | PF00397 | 0.603 |
DOC_WW_Pin1_4 | 344 | 349 | PF00397 | 0.590 |
DOC_WW_Pin1_4 | 350 | 355 | PF00397 | 0.528 |
DOC_WW_Pin1_4 | 370 | 375 | PF00397 | 0.661 |
LIG_14-3-3_CanoR_1 | 258 | 267 | PF00244 | 0.328 |
LIG_14-3-3_CanoR_1 | 305 | 315 | PF00244 | 0.278 |
LIG_14-3-3_CanoR_1 | 319 | 325 | PF00244 | 0.422 |
LIG_14-3-3_CanoR_1 | 362 | 369 | PF00244 | 0.671 |
LIG_14-3-3_CanoR_1 | 370 | 374 | PF00244 | 0.748 |
LIG_14-3-3_CanoR_1 | 486 | 495 | PF00244 | 0.736 |
LIG_Actin_WH2_2 | 244 | 260 | PF00022 | 0.319 |
LIG_Actin_WH2_2 | 481 | 496 | PF00022 | 0.558 |
LIG_APCC_ABBAyCdc20_2 | 172 | 178 | PF00400 | 0.348 |
LIG_APCC_ABBAyCdc20_2 | 415 | 421 | PF00400 | 0.536 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.551 |
LIG_FHA_1 | 113 | 119 | PF00498 | 0.382 |
LIG_FHA_1 | 169 | 175 | PF00498 | 0.416 |
LIG_FHA_1 | 188 | 194 | PF00498 | 0.423 |
LIG_FHA_1 | 307 | 313 | PF00498 | 0.319 |
LIG_FHA_1 | 319 | 325 | PF00498 | 0.632 |
LIG_FHA_1 | 334 | 340 | PF00498 | 0.719 |
LIG_FHA_1 | 480 | 486 | PF00498 | 0.523 |
LIG_FHA_2 | 205 | 211 | PF00498 | 0.288 |
LIG_FHA_2 | 305 | 311 | PF00498 | 0.378 |
LIG_FHA_2 | 382 | 388 | PF00498 | 0.474 |
LIG_FHA_2 | 428 | 434 | PF00498 | 0.559 |
LIG_FHA_2 | 487 | 493 | PF00498 | 0.599 |
LIG_GBD_Chelix_1 | 394 | 402 | PF00786 | 0.414 |
LIG_LIR_Apic_2 | 112 | 116 | PF02991 | 0.319 |
LIG_LIR_Apic_2 | 217 | 223 | PF02991 | 0.382 |
LIG_LIR_Gen_1 | 130 | 138 | PF02991 | 0.270 |
LIG_LIR_LC3C_4 | 239 | 244 | PF02991 | 0.323 |
LIG_LIR_Nem_3 | 120 | 125 | PF02991 | 0.272 |
LIG_LIR_Nem_3 | 144 | 149 | PF02991 | 0.492 |
LIG_LIR_Nem_3 | 263 | 269 | PF02991 | 0.288 |
LIG_LIR_Nem_3 | 344 | 349 | PF02991 | 0.603 |
LIG_NRBOX | 508 | 514 | PF00104 | 0.637 |
LIG_PDZ_Class_2 | 509 | 514 | PF00595 | 0.636 |
LIG_Pex14_2 | 121 | 125 | PF04695 | 0.288 |
LIG_SH2_CRK | 146 | 150 | PF00017 | 0.319 |
LIG_SH2_CRK | 254 | 258 | PF00017 | 0.344 |
LIG_SH2_STAT5 | 117 | 120 | PF00017 | 0.382 |
LIG_SH2_STAT5 | 167 | 170 | PF00017 | 0.382 |
LIG_SH3_3 | 145 | 151 | PF00018 | 0.309 |
LIG_SH3_3 | 296 | 302 | PF00018 | 0.382 |
LIG_SH3_3 | 328 | 334 | PF00018 | 0.696 |
LIG_SH3_3 | 336 | 342 | PF00018 | 0.639 |
LIG_SUMO_SIM_anti_2 | 52 | 60 | PF11976 | 0.420 |
LIG_SUMO_SIM_par_1 | 46 | 53 | PF11976 | 0.417 |
LIG_SUMO_SIM_par_1 | 83 | 89 | PF11976 | 0.267 |
LIG_WRC_WIRS_1 | 118 | 123 | PF05994 | 0.260 |
MOD_CDC14_SPxK_1 | 222 | 225 | PF00782 | 0.288 |
MOD_CDC14_SPxK_1 | 301 | 304 | PF00782 | 0.319 |
MOD_CDK_SPxK_1 | 219 | 225 | PF00069 | 0.288 |
MOD_CDK_SPxK_1 | 298 | 304 | PF00069 | 0.319 |
MOD_CDK_SPxxK_3 | 298 | 305 | PF00069 | 0.319 |
MOD_CDK_SPxxK_3 | 350 | 357 | PF00069 | 0.690 |
MOD_CDK_SPxxK_3 | 372 | 379 | PF00069 | 0.681 |
MOD_CK1_1 | 364 | 370 | PF00069 | 0.772 |
MOD_CK1_1 | 427 | 433 | PF00069 | 0.723 |
MOD_CK1_1 | 444 | 450 | PF00069 | 0.446 |
MOD_CK1_1 | 69 | 75 | PF00069 | 0.306 |
MOD_CK2_1 | 138 | 144 | PF00069 | 0.382 |
MOD_CK2_1 | 14 | 20 | PF00069 | 0.582 |
MOD_CK2_1 | 199 | 205 | PF00069 | 0.288 |
MOD_CK2_1 | 304 | 310 | PF00069 | 0.368 |
MOD_CK2_1 | 372 | 378 | PF00069 | 0.690 |
MOD_CK2_1 | 49 | 55 | PF00069 | 0.404 |
MOD_CK2_1 | 494 | 500 | PF00069 | 0.665 |
MOD_Cter_Amidation | 413 | 416 | PF01082 | 0.505 |
MOD_DYRK1A_RPxSP_1 | 370 | 374 | PF00069 | 0.531 |
MOD_GlcNHglycan | 16 | 19 | PF01048 | 0.573 |
MOD_GlcNHglycan | 294 | 297 | PF01048 | 0.377 |
MOD_GlcNHglycan | 350 | 353 | PF01048 | 0.497 |
MOD_GlcNHglycan | 357 | 360 | PF01048 | 0.599 |
MOD_GlcNHglycan | 426 | 429 | PF01048 | 0.746 |
MOD_GlcNHglycan | 433 | 436 | PF01048 | 0.795 |
MOD_GlcNHglycan | 443 | 446 | PF01048 | 0.510 |
MOD_GlcNHglycan | 468 | 471 | PF01048 | 0.706 |
MOD_GlcNHglycan | 473 | 476 | PF01048 | 0.708 |
MOD_GlcNHglycan | 69 | 72 | PF01048 | 0.397 |
MOD_GSK3_1 | 210 | 217 | PF00069 | 0.321 |
MOD_GSK3_1 | 28 | 35 | PF00069 | 0.387 |
MOD_GSK3_1 | 344 | 351 | PF00069 | 0.635 |
MOD_GSK3_1 | 361 | 368 | PF00069 | 0.688 |
MOD_GSK3_1 | 427 | 434 | PF00069 | 0.674 |
MOD_GSK3_1 | 43 | 50 | PF00069 | 0.368 |
MOD_GSK3_1 | 495 | 502 | PF00069 | 0.614 |
MOD_N-GLC_2 | 45 | 47 | PF02516 | 0.389 |
MOD_NEK2_1 | 138 | 143 | PF00069 | 0.300 |
MOD_NEK2_1 | 168 | 173 | PF00069 | 0.493 |
MOD_NEK2_1 | 185 | 190 | PF00069 | 0.280 |
MOD_NEK2_1 | 198 | 203 | PF00069 | 0.335 |
MOD_NEK2_1 | 204 | 209 | PF00069 | 0.326 |
MOD_NEK2_1 | 214 | 219 | PF00069 | 0.348 |
MOD_NEK2_1 | 369 | 374 | PF00069 | 0.718 |
MOD_NEK2_1 | 493 | 498 | PF00069 | 0.581 |
MOD_NEK2_2 | 117 | 122 | PF00069 | 0.260 |
MOD_PKA_1 | 304 | 310 | PF00069 | 0.361 |
MOD_PKA_2 | 304 | 310 | PF00069 | 0.348 |
MOD_PKA_2 | 318 | 324 | PF00069 | 0.509 |
MOD_PKA_2 | 361 | 367 | PF00069 | 0.666 |
MOD_PKA_2 | 369 | 375 | PF00069 | 0.743 |
MOD_PKA_2 | 493 | 499 | PF00069 | 0.619 |
MOD_PKA_2 | 78 | 84 | PF00069 | 0.321 |
MOD_Plk_1 | 389 | 395 | PF00069 | 0.408 |
MOD_Plk_2-3 | 381 | 387 | PF00069 | 0.491 |
MOD_Plk_4 | 117 | 123 | PF00069 | 0.331 |
MOD_Plk_4 | 127 | 133 | PF00069 | 0.258 |
MOD_Plk_4 | 163 | 169 | PF00069 | 0.491 |
MOD_Plk_4 | 210 | 216 | PF00069 | 0.351 |
MOD_Plk_4 | 28 | 34 | PF00069 | 0.447 |
MOD_ProDKin_1 | 112 | 118 | PF00069 | 0.323 |
MOD_ProDKin_1 | 219 | 225 | PF00069 | 0.288 |
MOD_ProDKin_1 | 298 | 304 | PF00069 | 0.319 |
MOD_ProDKin_1 | 333 | 339 | PF00069 | 0.603 |
MOD_ProDKin_1 | 344 | 350 | PF00069 | 0.589 |
MOD_ProDKin_1 | 370 | 376 | PF00069 | 0.655 |
MOD_SUMO_rev_2 | 188 | 196 | PF00179 | 0.386 |
TRG_DiLeu_BaEn_1 | 508 | 513 | PF01217 | 0.638 |
TRG_DiLeu_BaEn_2 | 127 | 133 | PF01217 | 0.288 |
TRG_DiLeu_LyEn_5 | 508 | 513 | PF01217 | 0.536 |
TRG_ENDOCYTIC_2 | 122 | 125 | PF00928 | 0.348 |
TRG_ENDOCYTIC_2 | 146 | 149 | PF00928 | 0.319 |
TRG_ENDOCYTIC_2 | 254 | 257 | PF00928 | 0.351 |
TRG_ER_diArg_1 | 101 | 103 | PF00400 | 0.270 |
TRG_ER_diArg_1 | 304 | 306 | PF00400 | 0.319 |
TRG_ER_diArg_1 | 73 | 75 | PF00400 | 0.323 |
TRG_Pf-PMV_PEXEL_1 | 463 | 467 | PF00026 | 0.513 |
TRG_Pf-PMV_PEXEL_1 | 486 | 491 | PF00026 | 0.557 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P8X6 | Leptomonas seymouri | 33% | 100% |
A0A0N1I0B6 | Leptomonas seymouri | 57% | 96% |
A0A1X0P919 | Trypanosomatidae | 54% | 100% |
A0A1X0PAW2 | Trypanosomatidae | 34% | 100% |
A0A3Q8IIG1 | Leishmania donovani | 30% | 100% |
A0A3Q8IND3 | Leishmania donovani | 90% | 98% |
A0A3Q8IPJ5 | Leishmania donovani | 28% | 100% |
A0A3Q8IVR8 | Leishmania donovani | 27% | 100% |
A0A3S7WYP4 | Leishmania donovani | 34% | 100% |
A0A3S7X2W3 | Leishmania donovani | 37% | 100% |
A0A3S7X7Y2 | Leishmania donovani | 35% | 100% |
A0A422NT49 | Trypanosoma rangeli | 27% | 72% |
A4H4S9 | Leishmania braziliensis | 22% | 100% |
A4H7V0 | Leishmania braziliensis | 26% | 72% |
A4HAS1 | Leishmania braziliensis | 33% | 100% |
A4HDU3 | Leishmania braziliensis | 34% | 100% |
A4HFA1 | Leishmania braziliensis | 29% | 100% |
A4HFC9 | Leishmania braziliensis | 28% | 78% |
A4HHN1 | Leishmania braziliensis | 36% | 100% |
A4HNT2 | Leishmania braziliensis | 27% | 100% |
A4HNU6 | Leishmania braziliensis | 77% | 98% |
A4HYH4 | Leishmania infantum | 28% | 100% |
A4I140 | Leishmania infantum | 34% | 100% |
A4I435 | Leishmania infantum | 30% | 100% |
A4I4U6 | Leishmania infantum | 37% | 100% |
A4I9Y5 | Leishmania infantum | 35% | 100% |
A4ICP8 | Leishmania infantum | 90% | 98% |
A4ICR2 | Leishmania infantum | 27% | 100% |
A8WUG4 | Caenorhabditis briggsae | 23% | 86% |
E9ALJ2 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 37% | 100% |
E9APX7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 26% | 72% |
E9AS98 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 29% | 100% |
E9ASJ2 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 26% | 100% |
E9ASK6 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 90% | 98% |
E9AX78 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 34% | 100% |
E9B4Z4 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 35% | 100% |
P51137 | Medicago sativa | 25% | 100% |
Q00168 | Drosophila melanogaster | 24% | 97% |
Q05116 | Xenopus laevis | 36% | 100% |
Q0PKV7 | Leishmania mexicana | 90% | 98% |
Q12701 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 28% | 87% |
Q4Q204 | Leishmania major | 27% | 100% |
Q4Q2Z2 | Leishmania major | 34% | 100% |
Q4Q7W2 | Leishmania major | 32% | 100% |
Q4QA98 | Leishmania major | 34% | 100% |
Q4QFK4 | Leishmania major | 26% | 82% |
Q9U6V4 | Leishmania donovani | 28% | 100% |
Q9Y077 | Leishmania major | 37% | 100% |
V5BDF5 | Trypanosoma cruzi | 27% | 78% |
V5BQF4 | Trypanosoma cruzi | 54% | 100% |